B細胞阻害剤の世界市場レポート2020

• 英文タイトル：Global B-Cell Inhibitor Sales Market Report 2020

• レポートコード：20QY06-00143 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,200,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社の当調査資料では、B細胞阻害剤のグローバル市場について種類別（アバタセプト、リツキシマブ、その他）、用途別（医療、実験、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・B細胞阻害剤市場の概要 ・世界の主要地域別B細胞阻害剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のB細胞阻害剤市場規模2015-2026：種類別（アバタセプト、リツキシマブ、その他） ・世界のB細胞阻害剤市場規模2015-2026：用途別（医療、実験、その他） ・B細胞阻害剤の北米市場規模2015-2020 ・B細胞阻害剤のヨーロッパ市場規模2015-2020 ・B細胞阻害剤の中国市場規模2015-2020 ・B細胞阻害剤の日本市場規模2015-2020 ・B細胞阻害剤の東南アジア市場規模2015-2020 ・B細胞阻害剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Abbvie、、Eli Lilly、、Bristol-Myers Squibb、、Celgene、、Celltrion、、Merck、） ・B細胞阻害剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・B細胞阻害剤の市場動向・機会・課題 ・調査の結論

Market Analysis and Insights: Global B-Cell Inhibitor Market

The global B-Cell Inhibitor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.

Global B-Cell Inhibitor Scope and Market Size

The global B-Cell Inhibitor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global B-Cell Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the B-Cell Inhibitor market is segmented into

Abatacept

Rituximab

Others

Segment by Application, the B-Cell Inhibitor market is segmented into

Medical Care

Experiment

Others

The B-Cell Inhibitor market is analysed and market size information is provided by regions (countries). Segment by Application, the B-Cell Inhibitor market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.

The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and B-Cell Inhibitor Market Share Analysis

B-Cell Inhibitor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in B-Cell Inhibitor business, the date to enter into the B-Cell Inhibitor market, B-Cell Inhibitor product introduction, recent developments, etc.

The major vendors covered:

Abbvie

Eli Lilly

Bristol-Myers Squibb

Celgene

Celltrion

Merck

…

レポート目次

---

Table of Contents

1 B-Cell Inhibitor Market Overview

1.1 B-Cell Inhibitor Product Scope

1.2 B-Cell Inhibitor Segment by Type

1.2.1 Global B-Cell Inhibitor Sales by Type (2020-2026)

1.2.2 Abatacept

1.2.3 Rituximab

1.2.4 Others

1.3 B-Cell Inhibitor Segment by Application

1.3.1 Global B-Cell Inhibitor Sales Comparison by Application (2020-2026)

1.3.2 Medical Care

1.3.3 Experiment

1.3.4 Others

1.4 B-Cell Inhibitor Market Estimates and Forecasts (2015-2026)

1.4.1 Global B-Cell Inhibitor Sales Growth Rate (2015-2026)

1.4.2 Global B-Cell Inhibitor Revenue and Growth Rate (2015-2026)

1.4.3 Global B-Cell Inhibitor Price Trends (2015-2026)

2 B-Cell Inhibitor Estimate and Forecast by Region

2.1 Global B-Cell Inhibitor Market Size by Region: 2015 VS 2020 VS 2026

2.2 Global B-Cell Inhibitor Retrospective Market Scenario by Region (2015-2020)

2.2.1 Global B-Cell Inhibitor Sales Market Share by Region (2015-2020)

2.2.2 Global B-Cell Inhibitor Revenue Market Share by Region (2015-2020)

2.3 Global B-Cell Inhibitor Market Estimates and Forecasts by Region (2021-2026)

2.3.1 Global B-Cell Inhibitor Sales Estimates and Forecasts by Region (2021-2026)

2.3.2 Global B-Cell Inhibitor Revenue Forecast by Region (2021-2026)

2.4 Geographic Market Analysis: Market Facts & Figures

2.4.1 United States B-Cell Inhibitor Estimates and Projections (2015-2026)

2.4.2 Europe B-Cell Inhibitor Estimates and Projections (2015-2026)

2.4.3 China B-Cell Inhibitor Estimates and Projections (2015-2026)

2.4.4 Japan B-Cell Inhibitor Estimates and Projections (2015-2026)

2.4.5 Southeast Asia B-Cell Inhibitor Estimates and Projections (2015-2026)

2.4.6 India B-Cell Inhibitor Estimates and Projections (2015-2026)

3 Global B-Cell Inhibitor Competition Landscape by Players

3.1 Global Top B-Cell Inhibitor Players by Sales (2015-2020)

3.2 Global Top B-Cell Inhibitor Players by Revenue (2015-2020)

3.3 Global B-Cell Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-Cell Inhibitor as of 2019)

3.4 Global B-Cell Inhibitor Average Price by Company (2015-2020)

3.5 Manufacturers B-Cell Inhibitor Manufacturing Sites, Area Served, Product Type

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3.7 Primary Interviews with Key B-Cell Inhibitor Players (Opinion Leaders)

4 Global B-Cell Inhibitor Market Size by Type

4.1 Global B-Cell Inhibitor Historic Market Review by Type (2015-2020)

4.1.1 Global B-Cell Inhibitor Sales Market Share by Type (2015-2020)

4.1.2 Global B-Cell Inhibitor Revenue Market Share by Type (2015-2020)

4.1.3 Global B-Cell Inhibitor Price by Type (2014-2020)

4.2 Global B-Cell Inhibitor Market Estimates and Forecasts by Type (2021-2026)

4.2.1 Global B-Cell Inhibitor Sales Forecast by Type (2021-2026)

4.2.2 Global B-Cell Inhibitor Revenue Forecast by Type (2021-2026)

4.2.3 Global B-Cell Inhibitor Price Forecast by Type (2021-2026)

5 Global B-Cell Inhibitor Market Size by Application

5.1 Global B-Cell Inhibitor Historic Market Review by Application (2015-2020)

5.1.1 Global B-Cell Inhibitor Sales Market Share by Application (2015-2020)

5.1.2 Global B-Cell Inhibitor Revenue Market Share by Application (2015-2020)

5.1.3 Global B-Cell Inhibitor Price by Application (2015-2020)

5.2 Global B-Cell Inhibitor Market Estimates and Forecasts by Application (2021-2026)

5.2.1 Global B-Cell Inhibitor Sales Forecast by Application (2021-2026)

5.2.2 Global B-Cell Inhibitor Revenue Forecast by Application (2021-2026)

5.2.3 Global B-Cell Inhibitor Price Forecast by Application (2021-2026)

3 North America B-Cell Inhibitor Market Facts & Figures

3.2 North America B-Cell Inhibitor Sales Market Share by Company (2015-2020)

3.3 North America B-Cell Inhibitor Sales Market Share by Type (2015-2020)

3.4 North America B-Cell Inhibitor Sales Market Share by Application (2015-2020)

4 Europe B-Cell Inhibitor Market Facts & Figures

4.2 Europe B-Cell Inhibitor Sales Market Share by Company (2015-2020)

4.3 Europe B-Cell Inhibitor Sales Market Share by Type (2015-2020)

4.4 Europe B-Cell Inhibitor Sales Market Share by Application (2015-2020)

5 China B-Cell Inhibitor Market Facts & Figures

5.2 China B-Cell Inhibitor Sales Market Share by Company (2015-2020)

5.3 China B-Cell Inhibitor Sales Market Share by Type (2015-2020)

5.4 China B-Cell Inhibitor Sales Market Share by Application (2015-2020)

6 Japan B-Cell Inhibitor Market Facts & Figures

6.2 Japan B-Cell Inhibitor Sales Market Share by Company (2015-2020)

6.3 Japan B-Cell Inhibitor Sales Market Share by Type (2015-2020)

6.4 Japan B-Cell Inhibitor Sales Market Share by Application (2015-2020)

7 Southeast Asia B-Cell Inhibitor Market Facts & Figures

7.2 Southeast Asia B-Cell Inhibitor Sales Market Share by Company (2015-2020)

7.3 Southeast Asia B-Cell Inhibitor Sales Market Share by Type (2015-2020)

7.4 Southeast Asia B-Cell Inhibitor Sales Market Share by Application (2015-2020)

8 India B-Cell Inhibitor Market Facts & Figures

8.2 India B-Cell Inhibitor Sales Market Share by Company (2015-2020)

8.3 India B-Cell Inhibitor Sales Market Share by Type (2015-2020)

8.4 India B-Cell Inhibitor Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in B-Cell Inhibitor Business

12.1 Abbvie

12.1.1 Abbvie B-Cell Inhibitor Corporation Information

12.1.2 Abbvie B-Cell Inhibitor Business Overview and Total Revenue

12.1.3 Abbvie B-Cell Inhibitor Sales, Revenue and Gross Margin (2015-2020)

12.1.4 Abbvie B-Cell Inhibitor Products Offered

12.1.5 Abbvie Recent Development

12.2 Eli Lilly

12.2.1 Eli Lilly B-Cell Inhibitor Corporation Information

12.2.2 Eli Lilly B-Cell Inhibitor Business Overview and Total Revenue

12.2.3 Eli Lilly B-Cell Inhibitor Sales, Revenue and Gross Margin (2015-2020)

12.2.4 Eli Lilly B-Cell Inhibitor Products Offered

12.2.5 Eli Lilly Recent Development

12.3 Bristol-Myers Squibb

12.3.1 Bristol-Myers Squibb B-Cell Inhibitor Corporation Information

12.3.2 Bristol-Myers Squibb B-Cell Inhibitor Business Overview and Total Revenue

12.3.3 Bristol-Myers Squibb B-Cell Inhibitor Sales, Revenue and Gross Margin (2015-2020)

12.3.4 Bristol-Myers Squibb B-Cell Inhibitor Products Offered

12.3.5 Bristol-Myers Squibb Recent Development

12.4 Celgene

12.4.1 Celgene B-Cell Inhibitor Corporation Information

12.4.2 Celgene B-Cell Inhibitor Business Overview and Total Revenue

12.4.3 Celgene B-Cell Inhibitor Sales, Revenue and Gross Margin (2015-2020)

12.4.4 Celgene B-Cell Inhibitor Products Offered

12.4.5 Celgene Recent Development

12.5 Celltrion

12.5.1 Celltrion B-Cell Inhibitor Corporation Information

12.5.2 Celltrion B-Cell Inhibitor Business Overview and Total Revenue

12.5.3 Celltrion B-Cell Inhibitor Sales, Revenue and Gross Margin (2015-2020)

12.5.4 Celltrion B-Cell Inhibitor Products Offered

12.5.5 Celltrion Recent Development

12.6 Merck

12.6.1 Merck B-Cell Inhibitor Corporation Information

12.6.2 Merck B-Cell Inhibitor Business Overview and Total Revenue

12.6.3 Merck B-Cell Inhibitor Sales, Revenue and Gross Margin (2015-2020)

12.6.4 Merck B-Cell Inhibitor Products Offered

12.6.5 Merck Recent Development

…

13 B-Cell Inhibitor Manufacturing Cost Analysis

13.1 B-Cell Inhibitor Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Key Raw Materials Price Trend

13.1.3 Key Suppliers of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.3 Manufacturing Process Analysis of B-Cell Inhibitor

13.4 B-Cell Inhibitor Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

14.1 Marketing Channel

14.2 B-Cell Inhibitor Distributors List

14.3 B-Cell Inhibitor Customers

15 Market Dynamics

15.1 Market Trends

15.2 Opportunities and Drivers

15.3 Challenges

15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix

17.1 Research Methodology

17.1.1 Methodology/Research Approach

17.1.2 Data Source

17.2 Author List

17.3 Disclaimer

List of Tables



Table 1. Global B-Cell Inhibitor Sales (K Pcs) Growth Rate by Type (2020-2026)

Table 2. Global B-Cell Inhibitor Sales (K Pcs) Comparison by Application (2020-2026)

Table 3. Global Market B-Cell Inhibitor Market Size (US$ Million) by Region:2015 VS 2020 &2026

Table 4. Global B-Cell Inhibitor Sales (K Pcs) by Region (2015-2020)

Table 5. Global B-Cell Inhibitor Sales Market Share by Region (2015-2020)

Table 6. Global B-Cell Inhibitor Revenue (US$ Million) Market Share by Region (2015-2020))

Table 7. Global B-Cell Inhibitor Revenue Share by Region (2015-2020)

Table 8. Global B-Cell Inhibitor Sales (K Pcs) Forecast by Region (2021-2026)

Table 9. Global B-Cell Inhibitor Sales Market Share Forecast by Region (2021-2026)

Table 10. Global B-Cell Inhibitor Revenue (US$ Million) Forecast by Region (2021-2026)

Table 11. Global B-Cell Inhibitor Revenue Share Forecast by Region (2021-2026)

Table 12. Global B-Cell Inhibitor (K Pcs) of Key Companies (2015-2020)

Table 13. Global B-Cell Inhibitor Sales Share by Company (2015-2020)

Table 14. Global B-Cell Inhibitor Revenue (US$ Million) by Company (2015-2020)

Table 15. Global B-Cell Inhibitor Revenue Share by Company (2015-2020)

Table 16. Global B-Cell Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-Cell Inhibitor as of 2019)

Table 17. Global B-Cell Inhibitor Average Price (USD/Pcs) of Key Company (2015-2020)

Table 18. Manufacturers B-Cell Inhibitor Manufacturing Sites and Area Served

Table 19. Manufacturers B-Cell Inhibitor Product Type

Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 21. Main Points Interviewed from Key B-Cell Inhibitor Players

Table 22. Global B-Cell Inhibitor Sales (K Pcs) by Type (2015-2020)

Table 23. Global B-Cell Inhibitor Sales Share by Type (2015-2020)

Table 24. Global B-Cell Inhibitor Revenue (US$ Million) Market Share by Type (2015-2020)

Table 25. Global B-Cell Inhibitor Price (K Pcs) by Type (2015-2020)

Table 26. Global B-Cell Inhibitor Sales Share by Type (2021-2026)

Table 27. Global B-Cell Inhibitor Revenue (US$ Million) Market Share by Type (2021-2026)

Table 28. Global B-Cell Inhibitor Revenue Share by Type (2021-2026)

Table 29. Global B-Cell Inhibitor Price (K Pcs) by Type (2021-2026)

Table 30. Global B-Cell Inhibitor Sales (K Pcs) by Application (2015-2020)

Table 31. Global B-Cell Inhibitor Sales Share by Application (2015-2020)

Table 32. Global B-Cell Inhibitor Revenue (US$ Million) Market Share by Application (2015-2020)

Table 33. Global B-Cell Inhibitor Price (K Pcs) by Application (2015-2020)

Table 34. Global B-Cell Inhibitor Sales (K Pcs) by Application (2021-2026)

Table 35. Global B-Cell Inhibitor Sales Share by Application (2021-2026)

Table 36. Global B-Cell Inhibitor Revenue (US$ Million) Market Share by Application (2021-2026)

Table 37. Global B-Cell Inhibitor Revenue Share by Application (2021-2026)

Table 38. Global B-Cell Inhibitor Price (K Pcs) by Application (2021-2026)

Table 39. United States B-Cell Inhibitor Sales (K Pcs) by Company (2015-2020)

Table 40. United States B-Cell Inhibitor Sales Market Share by Company (2015-2020)

Table 41. United States B-Cell Inhibitor Sales (K Pcs) by Type (2015-2020)

Table 42. United States B-Cell Inhibitor Sales Market Share by Type (2015-2020)

Table 43. United States B-Cell Inhibitor Sales (K Pcs) by Application (2015-2020)

Table 44. United States B-Cell Inhibitor Sales Market Share by Application (2015-2020)

Table 45. Europe B-Cell Inhibitor Sales (K Pcs) by Company (2015-2020)

Table 46. Europe B-Cell Inhibitor Sales Market Share by Company (2015-2020)

Table 47. Europe B-Cell Inhibitor Sales (K Pcs) by Type (2015-2020)

Table 48. Europe B-Cell Inhibitor Sales Market Share by Type (2015-2020)

Table 49. Europe B-Cell Inhibitor Sales (K Pcs) by Application (2015-2020)

Table 50. Europe B-Cell Inhibitor Sales Market Share by Type (2015-2020)

Table 51. China B-Cell Inhibitor Sales (K Pcs) by Company (2015-2020)

Table 52. China B-Cell Inhibitor Sales Market Share by Company (2015-2020)

Table 53. China B-Cell Inhibitor Sales (K Pcs) by Type (2015-2020)

Table 54. China B-Cell Inhibitor Sales Market Share by Type (2015-2020)

Table 55. China B-Cell Inhibitor Sales (K Pcs) by Application (2015-2020)

Table 56. China B-Cell Inhibitor Sales Market Share by Application (2015-2020)

Table 57. Japan B-Cell Inhibitor Sales (K Pcs) by Company (2015-2020)

Table 58. Japan B-Cell Inhibitor Sales Market Share by Company (2015-2020)

Table 59. Japan B-Cell Inhibitor Sales (K Pcs) by Type (2015-2020)

Table 60. Japan B-Cell Inhibitor Sales Market Share by Type (2015-2020)

Table 61. Japan B-Cell Inhibitor Sales (K Pcs) by Application (2015-2020)

Table 62. Japan B-Cell Inhibitor Sales Market Share by Application (2015-2020)

Table 63. Southeast Asia B-Cell Inhibitor Sales (K Pcs) by Company (2015-2020)

Table 64. Southeast Asia B-Cell Inhibitor Sales Market Share by Company (2015-2020)

Table 65. Southeast Asia B-Cell Inhibitor Sales (K Pcs) by Type (2015-2020)

Table 66. Southeast Asia B-Cell Inhibitor Sales Market Share by Type (2015-2020)

Table 67. Southeast Asia B-Cell Inhibitor Sales (K Pcs) by Type (2015-2020)

Table 68. Southeast Asia B-Cell Inhibitor Sales Market Share by Application (2015-2020)

Table 69. India B-Cell Inhibitor Sales (K Pcs) by Company (2015-2020)

Table 70. India B-Cell Inhibitor Sales Market Share by Company (2015-2020)

Table 71. India B-Cell Inhibitor Sales (K Pcs) by Type (2015-2020)

Table 72. India B-Cell Inhibitor Sales Market Share by Type (2015-2020)

Table 73. India B-Cell Inhibitor Sales (K Pcs) by Application (2015-2020)

Table 74. India B-Cell Inhibitor Sales Market Share by Application (2015-2020)

Table 75. Abbvie Corporation Information

Table 76. Abbvie Description and Business Overview

Table 77. Abbvie B-Cell Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 78. Abbvie B-Cell Inhibitor Product

Table 79. Abbvie Recent Development

Table 80. Eli Lilly Corporation Information

Table 81. Eli Lilly Description and Business Overview

Table 82. Eli Lilly B-Cell Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 83. Eli Lilly B-Cell Inhibitor Product

Table 84. Eli Lilly Recent Development

Table 85. Bristol-Myers Squibb Corporation Information

Table 86. Bristol-Myers Squibb Description and Business Overview

Table 87. Bristol-Myers Squibb B-Cell Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 88. Bristol-Myers Squibb B-Cell Inhibitor Product

Table 89. Bristol-Myers Squibb Recent Development

Table 90. Celgene Corporation Information

Table 91. Celgene Description and Business Overview

Table 92. Celgene B-Cell Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 93. Celgene B-Cell Inhibitor Product

Table 94. Celgene Recent Development

Table 95. Celltrion Corporation Information

Table 96. Celltrion Description and Business Overview

Table 97. Celltrion B-Cell Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 98. Celltrion B-Cell Inhibitor Product

Table 99. Celltrion Recent Development

Table 100. Merck Corporation Information

Table 101. Merck Description and Business Overview

Table 102. Merck B-Cell Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 103. Merck B-Cell Inhibitor Product

Table 104. Merck Recent Development

Table 105. Production Base and Market Concentration Rate of Raw Material

Table 106. Key Suppliers of Raw Materials

Table 107. B-Cell Inhibitor Distributors List

Table 108. B-Cell Inhibitor Customers List

Table 109. Market Key Trends

Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)

Table 111. Key Challenges

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. B-Cell Inhibitor Product Picture

Figure 2. Global B-Cell Inhibitor Sales Market Share by Type in 2020 & 2026

Figure 3. Type I Product Picture

Figure 4. Type II Product Picture

Figure 5. Global B-Cell Inhibitor Market Share by Application in 2020 & 2026

Figure 6. Medical Care Examples

Figure 7. Experiment Examples

Figure 8. Others Examples

Figure 9. Global B-Cell Inhibitor Sales (K Pcs) Growth Rate (2015-2026)

Figure 10. Global B-Cell Inhibitor Revenue (US$ Million) Growth Rate (2015-2026)

Figure 11. Global B-Cell Inhibitor Price Trends Growth Rate (2015-2026) (USD/Pcs)

Figure 12. Global B-Cell Inhibitor Revenue Market Share by Region: 2015 VS 2020

Figure 13. Global B-Cell Inhibitor Revenue Market Share by Region: 2021 VS 2026

Figure 14. United States B-Cell Inhibitor Revenue (Million USD) Growth Rate (2015-2026)

Figure 15. United States B-Cell Inhibitor Sales (K Pcs) Growth Rate (2015-2026)

Figure 16. Europe B-Cell Inhibitor Revenue (Million USD) Growth Rate (2015-2026)

Figure 17. Europe B-Cell Inhibitor Sales (Million USD) Growth Rate (2015-2026)

Figure 18. China B-Cell Inhibitor Revenue (Million USD) Growth Rate (2015-2026)

Figure 19. China B-Cell Inhibitor Sales (Million USD) and Growth Rate (2015-2026)

Figure 20. Japan B-Cell Inhibitor Revenue (Million USD) Growth Rate (2015-2026)

Figure 21. Japan B-Cell Inhibitor Sales (Million USD) Growth Rate (2015-2026)

Figure 22. Southeast Asia B-Cell Inhibitor Revenue (Million USD) Growth Rate (2015-2026)

Figure 23. Southeast Asia B-Cell Inhibitor Sales (Million USD) Growth Rate (2015-2026)

Figure 24. India B-Cell Inhibitor Revenue (Million USD) Growth Rate (2015-2026)

Figure 25. India B-Cell Inhibitor Sales (Million USD) Growth Rate (2015-2026)

Figure 26. Global 5 Largest B-Cell Inhibitor Players Market Share by Revenue in B-Cell Inhibitor 2015 & 2019

Figure 27. B-Cell Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 28. Global B-Cell Inhibitor Revenue Share by Type (2015-2020)

Figure 29. Global B-Cell Inhibitor Revenue Growth Rate by Type in 2015 & 2019

Figure 30. Global B-Cell Inhibitor Revenue Share by Application (2015-2020)

Figure 31. Global B-Cell Inhibitor Revenue Growth Rate by Application in 2015 & 2019

Figure 32. United States B-Cell Inhibitor Sales Market Share by Type in 2019

Figure 33. United States B-Cell Inhibitor Sales Market Share by Type in 2019

Figure 34. Europe B-Cell Inhibitor Sales Market Share by Company in 2019

Figure 35. Europe B-Cell Inhibitor Sales Market Share by Type in 2019

Figure 36. Europe B-Cell Inhibitor Sales Market Share by Application in 2019

Figure 37. China B-Cell Inhibitor Sales Market Share by Company in 2019

Figure 38. China B-Cell Inhibitor Sales Market Share by Type in 2019

Figure 39. China B-Cell Inhibitor Sales Market Share by Application in 2019

Figure 40. Japan B-Cell Inhibitor Sales Market Share by Company in 2019

Figure 41. Japan B-Cell Inhibitor Sales Market Share by Type in 2019

Figure 42. Japan B-Cell Inhibitor Sales Market Share by Application in 2019

Figure 43. Southeast Asia B-Cell Inhibitor Sales Market Share by Company in 2019

Figure 44. Southeast Asia B-Cell Inhibitor Sales Market Share by Type in 2019

Figure 45. Southeast Asia B-Cell Inhibitor Sales Market Share by Application in 2019

Figure 46. India B-Cell Inhibitor Sales Market Share by Company in 2019

Figure 47. India B-Cell Inhibitor Sales Market Share by Type in 2019

Figure 48. India B-Cell Inhibitor Sales Market Share by Application in 2019

Figure 49. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018

Figure 50. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018

Figure 51. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018

Figure 52. Celgene Total Revenue (US$ Million): 2019 Compared with 2018

Figure 53. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018

Figure 54. Merck Total Revenue (US$ Million): 2019 Compared with 2018

Figure 55. Key Raw Materials Price Trend

Figure 56. Manufacturing Cost Structure of B-Cell Inhibitor

Figure 57. Manufacturing Process Analysis of B-Cell Inhibitor

Figure 58. B-Cell Inhibitor Industrial Chain Analysis

Figure 59. Channels of Distribution

Figure 60. Distributors Profiles

Figure 61. Porter's Five Forces Analysis

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

---